BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2167697)

  • 1. Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
    Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
    Skin Pharmacol; 1990; 3(1):45-8. PubMed ID: 2167697
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes (PMN) in normal skin and LTB4-stimulated human skin.
    Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
    Agents Actions; 1991 Jan; 32(1-2):75-6. PubMed ID: 1647650
    [No Abstract]   [Full Text] [Related]  

  • 3. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.
    Goldman DW; Pickett WC; Goetzl EJ
    Biochem Biophys Res Commun; 1983 Nov; 117(1):282-8. PubMed ID: 6318749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
    Lee TH; Menica-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Biol Chem; 1984 Feb; 259(4):2383-9. PubMed ID: 6321468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes.
    Boggs JM; Goetzl EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():399-402. PubMed ID: 1847775
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils.
    Kragballe K; Voorhees JJ; Goetzl EJ
    J Invest Dermatol; 1987 May; 88(5):555-8. PubMed ID: 2437212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene B4 stimulation of an early elevation of phosphatidic acid mass in human neutrophils.
    Tou JS; Dola T
    Lipids; 1995 May; 30(5):373-81. PubMed ID: 7637556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of biological properties of synthetic and biological leukotriene B3.
    Evans J; Zamboni R; Nathaniel D; Leveillé C; Ford-Hutchinson AW
    Prostaglandins; 1985 Dec; 30(6):981-8. PubMed ID: 3003815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
    Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
    Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of leukotriene B4 and leukotriene B5 on calcium mobilization in human neutrophils.
    Seya A; Terano T; Tamura Y; Yoshida S
    Prostaglandins Leukot Essent Fatty Acids; 1988 Oct; 34(1):47-50. PubMed ID: 2852812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils.
    Prescott SM; Zimmerman GA; Seeger AR
    Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid.
    Payan DG; Wong MY; Chernov-Rogan T; Valone FH; Pickett WC; Blake VA; Gold WM; Goetzl EJ
    J Clin Immunol; 1986 Sep; 6(5):402-10. PubMed ID: 3021806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary supplementation of highly purified eicosapentaenoic acid and docosahexaenoic acid on arachidonic acid metabolism in leukocytes and leukocyte function in healthy volunteers.
    Terano T; Hirai A; Tamura Y; Kumagai A; Yoshida S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():880-5. PubMed ID: 2823575
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukotriene B3, leukotriene B4 and leukotriene B5; binding to leukotriene B4 receptors on rat and human leukocyte membranes.
    Charleson S; Evans JF; Zamboni RJ; Leblanc Y; Fitzsimmons BJ; Leveillé C; Dupuis P; Ford-Hutchinson AW
    Prostaglandins; 1986 Oct; 32(4):503-16. PubMed ID: 3025936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.
    Camp RD; Woollard PM; Mallet AI; Fincham NJ; Ford-Hutchinson AW; Bray MA
    Prostaglandins; 1982 May; 23(5):631-41. PubMed ID: 6289379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.
    Gray GD; Ohlmann GM; Morton DR; Schaub RG
    Agents Actions; 1986 Jun; 18(3-4):401-6. PubMed ID: 3019111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function.
    Lee TH; Hoover RL; Williams JD; Sperling RI; Ravalese J; Spur BW; Robinson DR; Corey EJ; Lewis RA; Austen KF
    N Engl J Med; 1985 May; 312(19):1217-24. PubMed ID: 2985986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4.
    Goldman DW; Goetzl EJ
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):373-7. PubMed ID: 6088613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.